Consainsights logo
Reports / Fondaparinux Market

Fondaparinux Market

Fondaparinux Market Research Report – Segmented By Product Type (Branded, Generics) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Fondaparinux Market was valued at US $3,930.36 million in 2021 and is projected to grow at 7.44% CAGR over the forecast period to reach US $6,044.66 million by 2027. Fondaparinux Market represented US $525.34 million opportunity over 2019-2021 and estimated to create US $2,114.30 million opportunity in 2027 over 2021.

Fondaparinux from Consainsights analyses the Fondaparinux Market in the Life Sciences industry over the forecast period to 2027.

Fondaparinux research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Fondaparinux segmentation includes Product Type and Geography.

Based on the Product Type, the Fondaparinux analysis covers Branded, Generics.

In Product Type segment, Branded segment has highest cagr growth of 6.58%.

Based on the region, the Fondaparinux analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Aurobindo Pharma Ltd, Dr. Reddy's Laboratories Ltd, Mylan Inc., Jiangsu Hengrui Medicine Co. Ltd, Scinopharm Taiwan Ltd, Pfizer Inc, Novartis AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Bristol Myers Squibb Company, Aspen Pharmacare Holdings Limited, Eisai Co., Ltd., Apotex Inc, Kaifeng Pharmaceutical Group Co., Ltd, Lupin Pharmaceutical, Inc, Alchemia Ltd and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

  • Revenue Share (%), By Product Type (2021)
    Revenue Share (%), By Product Type (2021)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Product Type

  • Branded accounted for US$1829.59 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Generics accounted for US$2100.77 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Fondaparinux Market Y-o-Y Growth (USD million), By Product Type 2019 - 2027
Fondaparinux Market Y-o-Y Growth (USD million), By Product Type 2019 - 2027
Fondaparinux Market Size, By Product Type, 2019-2027 (USD million)
Fondaparinux Market Size, By Product Type, 2019-2027 (USD million)

The Branded segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Branded: global Fondaparinux Market Revenue Opportunity (Us$ Mn)
Branded: global Fondaparinux Market Revenue Opportunity (Us$ Mn)

The Generics segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Generics: global Fondaparinux Market Revenue Opportunity (Us$ Mn)
Generics: global Fondaparinux Market Revenue Opportunity (Us$ Mn)
04

North America

  • In 2021, North America segment accounted for US$3930.36 Bn and is expected grow with a CAGR of 7.44% over the forecast years.
  • In North America, United States accounted for US$1769.74 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Canada accounted for US$2160.62 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
North America Fondaparinux Market, By Country, 2019-2027 (USD million)
North America Fondaparinux Market, By Country, 2019-2027 (USD million)
North America Fondaparinux Market - Market Opportunity (USD million), 2019, 2021 & 2027
North America Fondaparinux Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Product Type - North America (2021)
Revenue Share (%), By Product Type - North America (2021)
North America Fondaparinux Market, By Country, 2019-2027 (USD million)
North America Fondaparinux Market, By Country, 2019-2027 (USD million)
United States Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
United States Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Canada Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Canada Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
05

Europe

  • In 2021, Europe segment accounted for US$3930.36 Bn and is expected grow with a CAGR of 7.44% over the forecast years.
  • In Europe, Germany accounted for US$1521.46 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • United Kingdom accounted for US$970.36 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • France accounted for US$567.47 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Spain accounted for US$433.71 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Russia accounted for US$300.25 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Italy accounted for US$126.44 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Europe accounted for US$10.66 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Europe Fondaparinux Market, By Country, 2019-2027 (USD million)
Europe Fondaparinux Market, By Country, 2019-2027 (USD million)
Europe Fondaparinux Market - Market Opportunity (USD million), 2019, 2021 & 2027
Europe Fondaparinux Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Product Type - Europe (2021)
Revenue Share (%), By Product Type - Europe (2021)
Europe Fondaparinux Market, By Country, 2019-2027 (USD million)
Europe Fondaparinux Market, By Country, 2019-2027 (USD million)
Germany Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Germany Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
United Kingdom Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
United Kingdom Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
France Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
France Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Spain Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Spain Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Russia Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Russia Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Italy Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Italy Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Europe Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Europe Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
06

Asia-Pacific

  • In 2021, Asia-Pacific segment accounted for US$3930.36 Bn and is expected grow with a CAGR of 7.44% over the forecast years.
  • In Asia-Pacific, China accounted for US$1751.05 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Japan accounted for US$914.86 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • India accounted for US$574.09 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Southeast Asia accounted for US$493.08 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Australia & New Zealand accounted for US$138.68 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Asia-Pacific accounted for US$58.59 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Asia-Pacific Fondaparinux Market, By Country, 2019-2027 (USD million)
Asia-Pacific Fondaparinux Market, By Country, 2019-2027 (USD million)
Asia-Pacific Fondaparinux Market - Market Opportunity (USD million), 2019, 2021 & 2027
Asia-Pacific Fondaparinux Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Product Type - Asia-Pacific (2021)
Revenue Share (%), By Product Type - Asia-Pacific (2021)
Asia-Pacific Fondaparinux Market, By Country, 2019-2027 (USD million)
Asia-Pacific Fondaparinux Market, By Country, 2019-2027 (USD million)
China Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
China Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Japan Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Japan Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
India Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
India Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Southeast Asia Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Southeast Asia Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Australia & New Zealand Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Australia & New Zealand Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Asia-Pacific Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Asia-Pacific Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
07

Middle East & Africa

Based on the Middle East & Africa, the Fondaparinux Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Fondaparinux Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Fondaparinux Size, 2019-2027 (Us$ Mn)
Middle East & Africa Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Middle East & Africa Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Middle East Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Middle East Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Africa Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Africa Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Middle East & Africa Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Middle East & Africa Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
08

Latin America

  • In 2021, Latin America segment accounted for US$3930.36 Bn and is expected grow with a CAGR of 7.44% over the forecast years.
  • In Latin America, Brazil accounted for US$1731.69 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Argentina accounted for US$1196.46 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Mexico accounted for US$414.74 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Colombia accounted for US$298.51 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Latin America accounted for US$288.96 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Latin America Fondaparinux Market, By Country, 2019-2027 (USD million)
Latin America Fondaparinux Market, By Country, 2019-2027 (USD million)
Latin America Fondaparinux Market - Market Opportunity (USD million), 2019, 2021 & 2027
Latin America Fondaparinux Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Product Type - Latin America (2021)
Revenue Share (%), By Product Type - Latin America (2021)
Latin America Fondaparinux Market, By Country, 2019-2027 (USD million)
Latin America Fondaparinux Market, By Country, 2019-2027 (USD million)
Brazil Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Brazil Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Argentina Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Argentina Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Mexico Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Mexico Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Colombia Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Colombia Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Latin America Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Latin America Fondaparinux Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
09

Company Analysis

  • Aurobindo Pharma Ltd
  • Dr. Reddy's Laboratories Ltd
  • Mylan Inc.
  • Jiangsu Hengrui Medicine Co. Ltd
  • Scinopharm Taiwan Ltd
  • Pfizer Inc
  • Novartis AG
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Bristol Myers Squibb Company
  • Aspen Pharmacare Holdings Limited
  • Eisai Co., Ltd.
  • Apotex Inc
  • Kaifeng Pharmaceutical Group Co., Ltd
  • Lupin Pharmaceutical, Inc
  • Alchemia Ltd